. "2010"^^ . . "Kenneth D. Knight"@en . . . . . . . . . "2020"^^ . . . . "2020"^^ . "Invitae-logo.png"@en . "6.089E8"^^ . . . "2.796E8"^^ . . . . . . . "Invitae Corp."@en . "1099089388"^^ . . . . . "Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million."@en . . . . "10593"^^ . . . . . . "NYSE:NVTA"@en . . . . "Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million."@en . . . . "1666393"^^ . "-US$608.9 million"@en . . . "2.796E8"^^ . . "Genetic testing"@en . "2020"^^ . . . . . "San Francisco, California, U.S."@en . . "Invitae"@en . . . . "Invitae Corp."@en . . . . . .